A Medical Device Daily
Danaher (Washington) reported that it has received clearance from the antitrust authorities in Germany and Austria to consummate the tender offer by its wholly owned subsidiary for all of the outstanding shares of common stock of Sybron Dental Specialties (Newport Beach, California).
The acquisition, which has been valued at about $2 billion, was first unveiled in April (Medical Device Daily, April 13, 2006).
Danaher previously received notification of early termination of the waiting period under Hart-Scott-Rodino regulations and now has all antitrust clearances required.
Danaher's tender offer for Sybron Dental is scheduled to expire at midnight, EST, on Monday. The offer remains subject to customary conditions, including tender of a majority of the outstanding shares into the offer and the absence of a material adverse effect with respect to Sybron Dental.
Danaher is a manufacturer of professional instrumentation, industrial technologies and tools and components.
Sybron and its subsidiaries manufacture a range of products for the dental profession, including the specialty markets of orthodontics, endodontics and implantology, and a variety of infection prevention products for use by the medical profession.